DCF Advisers, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$116,851
-45.0%
30,430
-53.0%
0.06%
-42.9%
Q2 2023$212,426
+20.6%
64,764
-5.1%
0.11%
+3.7%
Q1 2023$176,120
+34.8%
68,264
-2.8%
0.11%
+22.7%
Q4 2022$130,691
-56.3%
70,264
-56.8%
0.09%
-54.4%
Q3 2022$299,000
-2.0%
162,701
+14.8%
0.19%
+6.0%
Q2 2022$305,000
-31.5%
141,7010.0%0.18%
-6.7%
Q1 2022$445,000
-2.2%
141,7010.0%0.20%
+5.4%
Q4 2021$455,000
-4.4%
141,7010.0%0.18%
-11.9%
Q3 2021$476,000
-12.8%
141,701
+1.4%
0.21%
+8.8%
Q2 2021$546,000
+24.7%
139,701
+28.2%
0.19%
+1.6%
Q1 2021$438,000109,0010.19%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders